Communicating Clinical Trial Data: Timing Remains Key Challenge for Marke...( CHAPEL HILL N.C. Feb. 27 /- Effec...),Health

CHAPEL HILL, N.C., Feb. 27 /PRNewswire/ -- Effective communication of clinical trials can help transform an active chemical compound into a blockbuster brand. How, when, and to whom the sophisticated information of clinical trials must be delivered -- these are some of the key questions pharmaceutical companies face.

"From Breakthrough to Blockbuster: Best Practices in Communicating Clinical Trial Results." -- A benchmarking report by Best Practices, LLC, presents how best-in-class pharmaceutical companies communicate clinical trial results. These findings will aid executives in making informed budget, resource allocation, and process improvement decisions as they prepare to release study findings.

Scope of the report

-- Choosing winning tactics for communicating study findings to

physicians, managed care organizations, investors and consumers

-- How to tailor communication, to specialist and primary care

physicians, based on their needs

-- Communication Toolkit that walks executives through the communication

process from the planning stages of a large clinical trial through the

post-launch period

The report is based on in-depth interviews and survey responses gathered from pharmaceutical executives at companies including Abbott, AstraZeneca, Aventis, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen, Merck, Novartis, Schering-Plough and Wyeth.

Download a complimentary research summary including sample best practices and data charts by clicking at http://www3.best-in-class.com/rr915.htm . For more information, contact Cameron Tew at 919-767-9246 or at ctew@best-in-class.com .

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, a pharmaceutical research and consulting firm, conducts work based on the principle that organizations can chart a course to superior economic performance b
'/>"/>